Inozyme Pharma, Inc. (INZY)
NASDAQ: INZY · Real-Time Price · USD
1.360
-0.020 (-1.45%)
At close: Feb 4, 2025, 4:00 PM
1.390
+0.030 (2.21%)
After-hours: Feb 4, 2025, 7:17 PM EST
Inozyme Pharma Market Cap
Inozyme Pharma has a market cap or net worth of $87.37 million as of February 4, 2025. Its market cap has decreased by -66.40% in one year.
Market Cap
87.37M
Enterprise Value
2.55M
1-Year Change
-66.40%
Ranking
Category
Stock Price
$1.36
Market Cap Chart
Since July 24, 2020, Inozyme Pharma's market cap has decreased from $356.32M to $87.37M, a decrease of -75.48%. That is a compound annual growth rate of -26.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 3, 2025 | 88.65M | -50.18% |
| Dec 31, 2024 | 177.95M | -32.37% |
| Dec 29, 2023 | 263.10M | 520.31% |
| Dec 30, 2022 | 42.41M | -73.72% |
| Dec 31, 2021 | 161.39M | -66.54% |
| Dec 31, 2020 | 482.42M | 35.39% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 729.74B |
| UnitedHealth Group | 504.48B |
| Novo Nordisk | 367.70B |
| Johnson & Johnson | 365.65B |
| AbbVie | 336.00B |
| Merck & Co. | 252.43B |
| Thermo Fisher Scientific | 227.11B |
| Abbott Laboratories | 222.79B |